SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001016169-11-000027
Filing Date
2011-11-08
Accepted
2011-11-08 17:16:12
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 q10sept.htm 10-Q 457012
2 ex311.htm EX-31.1 14751
3 ex312.htm EX-31.2 15530
4 ex321.htm EX-32.1 8612
5 ex322.htm EX-32.2 7877
  Complete submission text file 0001016169-11-000027.txt   1703018

Data Files

Seq Description Document Type Size
6 ais-20110930.xml EX-101.INS 174229
7 ais-20110930.xsd EX-101.SCH 11461
8 ais-20110930_cal.xml EX-101.CAL 37828
9 ais-20110930_lab.xml EX-101.LAB 132127
10 ais-20110930_pre.xml EX-101.PRE 77454
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 10-Q | Act: 34 | File No.: 001-32302 | Film No.: 111188720
SIC: 3841 Surgical & Medical Instruments & Apparatus